MariMed Stock Guidance | OTC:MRMD

Comments

MariMed Inc Stock Guidance

MRMDOTCQB

Trade with Public

$0.0761

0.0011.33%

At close: Mar 19, 5:00 PM EST

$0.0828

0.00678.80%

After Hours: Feb 23, 8:01 AM EST

Conference Call: The most recent conference call started at 8:00 AM, 7 days ago

Click to view the webcast

Overview News EarningsGuidanceAnalyst Ratings Insider Trades Short Interest

MariMed (MRMD) last issued guidance on November 6, 2024 for fiscal year 2024. The company guided revenue in the range of $157.51M - $160.49M for the period.

Compared to prior guidance, MariMed maintained its revenue forecast from a prior range of $156.03M - $159.00M.

MariMed has issued 8 guidance updates between May 10, 2022 and November 6, 2024. During this period, the company raised its outlook 2 times and lowered it 2 times, providing investors with insight into management's evolving expectations.

Latest Guidance Date

Nov 6, 2024

Guidance Period

Full Year 2024

Revenue Guidance Range

$157.51M - $160.49M

MariMed Guidance History

Review all historical guidance issued by MariMed, including EPS and revenue forecasts across quarterly and annual periods.

Loading calendar...

FAQ

What is the most recent guidance for MariMed (MRMD)?

The most recent guidance for MariMed (MRMD) was reported on November 6, 2024 for the fiscal year 2024. MariMed forecasted revenue between $157.51M and $160.49M for the period.

What revenue range did MariMed (MRMD) guide for?

MariMed (MRMD) guided revenue in the range of $157.51M to $160.49M for the fiscal year 2024.

Did MariMed (MRMD) raise or lower guidance?

MariMed (MRMD) maintained its revenue guidance from a prior range of $156.03M - $159.00M to $157.51M - $160.49M for the fiscal year 2024.

When did MariMed (MRMD) last issue guidance?

MariMed (MRMD) last issued guidance on November 6, 2024 for the fiscal year 2024.

MariMed (MRMD) last issued guidance on November 6, 2024 for fiscal year 2024. The company guided revenue in the range of $157.51M - $160.49M for the period.

Compared to prior guidance, MariMed maintained its revenue forecast from a prior range of $156.03M - $159.00M.

Latest Guidance Date

Nov 6, 2024

Guidance Period

Full Year 2024

Revenue Guidance Range

$157.51M - $160.49M

MariMed Guidance History

Review all historical guidance issued by MariMed, including EPS and revenue forecasts across quarterly and annual periods.

											Get Alert
11/06/2024	MRMD	MariMed	FY	2024	—	—	—	$157.51M	$160.49M	$163.05M	Get Alert
08/07/2024	MRMD	MariMed	FY	2024	—	—	—	$156.03M	$159.00M	$162.00M	Get Alert
05/08/2024	MRMD	MariMed	FY	2024	—	—	—	$156.03M	$159.00M	$157.35M	Get Alert
03/06/2024	MRMD	MariMed	FY	2024	—	—	—	$156.03M	$159.00M	$173.77M	Get Alert
11/08/2023	MRMD	MariMed	FY	2023	—	—	—	$148.00M	$150.00M	$152.35M	Get Alert
08/02/2023	MRMD	MariMed	FY	2023	—	—	—	$150.00M	—	$151.45M	Get Alert
05/08/2023	MRMD	MariMed	FY	2023	—	—	—	$150.00M	—	$149.65M	Get Alert
03/01/2023	MRMD	MariMed	FY	2023	—	—	—	$150.00M	—	$152.80M	Get Alert
11/07/2022	MRMD	MariMed	FY	2022	—	—	—	$132.00M	$135.00M	$135.80M	Get Alert
08/08/2022	MRMD	MariMed	FY	2022	—	—	—	$135.00M	$140.00M	$140.80M	Get Alert
05/10/2022	MRMD	MariMed	FY	2022	—	—	—	$145.00M	$150.00M	$141.65M	Get Alert

Loading calendar...

FAQ

What is the most recent guidance for MariMed (MRMD)?

The most recent guidance for MariMed (MRMD) was reported on November 6, 2024 for the fiscal year 2024. MariMed forecasted revenue between $157.51M and $160.49M for the period.

What revenue range did MariMed (MRMD) guide for?

MariMed (MRMD) guided revenue in the range of $157.51M to $160.49M for the fiscal year 2024.

Did MariMed (MRMD) raise or lower guidance?

MariMed (MRMD) maintained its revenue guidance from a prior range of $156.03M - $159.00M to $157.51M - $160.49M for the fiscal year 2024.

When did MariMed (MRMD) last issue guidance?

MariMed (MRMD) last issued guidance on November 6, 2024 for the fiscal year 2024.

											Get Alert
11/06/2024	MRMD	MariMed	FY	2024	—	—	—	$157.51M	$160.49M	$163.05M	Get Alert
08/07/2024	MRMD	MariMed	FY	2024	—	—	—	$156.03M	$159.00M	$162.00M	Get Alert
05/08/2024	MRMD	MariMed	FY	2024	—	—	—	$156.03M	$159.00M	$157.35M	Get Alert
03/06/2024	MRMD	MariMed	FY	2024	—	—	—	$156.03M	$159.00M	$173.77M	Get Alert
11/08/2023	MRMD	MariMed	FY	2023	—	—	—	$148.00M	$150.00M	$152.35M	Get Alert
08/02/2023	MRMD	MariMed	FY	2023	—	—	—	$150.00M	—	$151.45M	Get Alert
05/08/2023	MRMD	MariMed	FY	2023	—	—	—	$150.00M	—	$149.65M	Get Alert
03/01/2023	MRMD	MariMed	FY	2023	—	—	—	$150.00M	—	$152.80M	Get Alert
11/07/2022	MRMD	MariMed	FY	2022	—	—	—	$132.00M	$135.00M	$135.80M	Get Alert
08/08/2022	MRMD	MariMed	FY	2022	—	—	—	$135.00M	$140.00M	$140.80M	Get Alert
05/10/2022	MRMD	MariMed	FY	2022	—	—	—	$145.00M	$150.00M	$141.65M	Get Alert

Benzinga

Benzinga

MariMed Inc Stock Guidance

MariMed Guidance History

FAQ

What is the most recent guidance for MariMed (MRMD)?

What revenue range did MariMed (MRMD) guide for?

Did MariMed (MRMD) raise or lower guidance?

When did MariMed (MRMD) last issue guidance?

MariMed Guidance History

FAQ

What is the most recent guidance for MariMed (MRMD)?

What revenue range did MariMed (MRMD) guide for?

Did MariMed (MRMD) raise or lower guidance?

When did MariMed (MRMD) last issue guidance?